{"id":51442,"date":"2023-09-20T09:21:39","date_gmt":"2023-09-20T09:21:39","guid":{"rendered":"https:\/\/medsname.com\/arkamin\/"},"modified":"2026-05-01T10:49:11","modified_gmt":"2026-05-01T10:49:11","slug":"arkamin","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/arkamin\/","title":{"rendered":"Arkamin"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 Rychl\u00e1 odpov\u011b\u010f \u2014 Co je Arkamin?<\/h3>\n<p style=\"margin:0;\"><strong>Arkamin<\/strong> je <strong>100 mcg tableta Clonidinu<\/strong> od Torrent Pharma \u2014 <strong>centr\u00e1ln\u011b p\u016fsob\u00edc\u00ed agonista alfa-2 adrenergn\u00edch receptor\u016f (imidazolin), kter\u00fd sni\u017euje sympatick\u00fd v\u00fddej<\/strong>, p\u016fsob\u00ed na <strong>presynaptick\u00e9 alfa-2 adrenergn\u00ed receptory (a imidazolin-1 receptory) v rostr\u00e1ln\u00ed ventrolater\u00e1ln\u00ed medulle<\/strong>. Clonidin byl uveden na trh spole\u010dnost\u00ed Boehringer Ingelheim v roce 1966 jako <strong>Catapres<\/strong>. P\u016fvodn\u011b syntetizov\u00e1n jako nosn\u00ed dekongestant, n\u00e1hodn\u00e9 pozorov\u00e1n\u00ed v\u00fdrazn\u00e9 hypotenze u dobrovoln\u00edka v klinick\u00e9 studii vedlo k jeho p\u0159e\u0159azen\u00ed jako antihypertenziva. Modern\u00ed pou\u017eit\u00ed zahrnuje hypertenzi (\u010dtvrt\u00e1 linie a hypertenzn\u00ed urgentn\u00ed stavy), <strong>ADHD<\/strong> (schv\u00e1leno FDA v USA jako Kapvay ER), <strong>abstinen\u010dn\u00ed p\u0159\u00edznaky opioid\u016f a nikotinu<\/strong>, vazomotorick\u00e9 p\u0159\u00edznaky menopauzy, Tourett\u016fv syndrom, adjuvans p\u0159i bolesti (intratek\u00e1ln\u00ed) a p\u0159edopera\u010dn\u00ed medikaci. Polo\u010das 12-16 hodin (peror\u00e1ln\u011b); 20-24 hodin (transderm\u00e1ln\u00ed n\u00e1plast); n\u00e1stup \u00fa\u010dinku 30-60 minut (peror\u00e1ln\u011b); maxim\u00e1ln\u00ed plazmatick\u00e1 koncentrace 1-3 hodiny; antihypertenzn\u00ed \u00fa\u010dinek 2-4 hodiny; doba trv\u00e1n\u00ed 8-12 hodin. Hlavn\u00ed indikace: <strong>rezistentn\u00ed nebo \u010dtvrt\u00e1 linie hypertenze, hypertenzn\u00ed urgentn\u00ed stav (peror\u00e1ln\u00ed\/sublingu\u00e1ln\u00ed), ADHD, abstinen\u010dn\u00ed p\u0159\u00edznaky opioid\u016f\/nicotinu, n\u00e1valy horka v menopauze, bolest a anestetick\u00e9 dopl\u0148ky<\/strong>. Typick\u00e9 d\u00e1vkov\u00e1n\u00ed: <strong>Chronick\u00e1 hypertenze:<\/strong> 100 mcg (0,1 mg) dvakr\u00e1t a\u017e t\u0159ikr\u00e1t denn\u011b, s titrac\u00ed na obvykl\u00e9 maximum 800 mcg\/den. <strong>Nen\u00ed antihypertenzivem prvn\u00ed volby<\/strong> \u2014 vyhrazeno pro \u010dtvrtou\/p\u00e1tou linii po ACEi\/ARB, CCB, thiazidech a spironolaktonu. <strong>Hypertenzn\u00ed urgentn\u00ed stav (peror\u00e1ln\u00ed):<\/strong> 100-200 mcg n\u00e1stupn\u00ed d\u00e1vka, pot\u00e9 100 mcg ka\u017edou hodinu a\u017e do 600 mcg; sni\u017euje TK o 10-20 % b\u011bhem 1-2 hodin. Nen\u00ed ur\u010deno pro hypertenzn\u00ed emergenci (po\u0161kozen\u00ed c\u00edlov\u00fdch org\u00e1n\u016f) \u2014 pou\u017eijte intraven\u00f3zn\u00ed l\u00e1tky. <strong>Nikdy nep\u0159eru\u0161ujte u\u017e\u00edv\u00e1n\u00ed Arkaminu n\u00e1hle<\/strong> \u2014 rebound hypertenze je z\u00e1va\u017en\u00e1 a potenci\u00e1ln\u011b \u017eivot ohro\u017euj\u00edc\u00ed. U v\u011bt\u0161iny hypertonik\u016f modern\u00ed l\u00e9\u010dba za\u010d\u00edn\u00e1 ACE inhibitorem\/ARB, blok\u00e1torem kalciov\u00fdch kan\u00e1l\u016f, thiazidem a spironolaktonem, ne\u017e se p\u0159istoup\u00ed k alfa-blok\u00e1toru nebo centr\u00e1ln\u011b p\u016fsob\u00edc\u00ed l\u00e1tce.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">Co je Arkamin?<\/h2>\n<p>Arkamin je peror\u00e1ln\u00ed tableta Clonidinu 100 mcg od Torrent Pharma, dod\u00e1van\u00e1 v balen\u00ed po 30-90 tablet\u00e1ch. Clonidin byl uveden na trh spole\u010dnost\u00ed Boehringer Ingelheim v roce 1966 jako <strong>Catapres<\/strong>. P\u016fvodn\u011b syntetizov\u00e1n jako nosn\u00ed dekongestant, n\u00e1hodn\u00e9 pozorov\u00e1n\u00ed v\u00fdrazn\u00e9 hypotenze u dobrovoln\u00edka v klinick\u00e9 studii vedlo k jeho p\u0159e\u0159azen\u00ed jako antihypertenziva. Modern\u00ed pou\u017eit\u00ed zahrnuje hypertenzi (\u010dtvrt\u00e1 linie a hypertenzn\u00ed urgentn\u00ed stavy), <strong>ADHD<\/strong> (schv\u00e1leno FDA v USA jako Kapvay ER), <strong>abstinen\u010dn\u00ed p\u0159\u00edznaky opioid\u016f a nikotinu<\/strong>, vazomotorick\u00e9 p\u0159\u00edznaky menopauzy, Tourett\u016fv syndrom, dopl\u0148ky bolesti (intratek\u00e1ln\u00ed) a p\u0159edmedikace p\u0159ed anestezi\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">Jak Clonidin funguje<\/h2>\n<p>Clonidin p\u016fsob\u00ed na <strong>presynaptick\u00e9 alfa-2 adrenergn\u00ed receptory (a imidazolin-1 receptory) v rostr\u00e1ln\u00ed ventrolater\u00e1ln\u00ed medulle<\/strong>. N\u00e1sledn\u00e9 \u00fa\u010dinky:<\/p>\n<ul>\n<li><strong>Sn\u00ed\u017een\u00fd centr\u00e1ln\u00ed sympatick\u00fd v\u00fdstup<\/strong> \u2014 aktivace presynaptick\u00fdch alfa-2 receptor\u016f v rostr\u00e1ln\u00ed ventrolater\u00e1ln\u00ed prodlou\u017een\u00e9 m\u00ed\u0161e potla\u010duje sestupn\u00fd sympatick\u00fd tonus perifern\u00edho c\u00e9vn\u00edho \u0159e\u010di\u0161t\u011b a srdce<\/li>\n<li><strong>Sn\u00ed\u017een\u00e1 hladina noradrenalinu v plazm\u011b<\/strong> \u2014 cirkuluj\u00edc\u00ed katecholaminy klesnou o 30-50 % b\u011bhem n\u011bkolika hodin; tepov\u00e1 frekvence se sn\u00ed\u017e\u00ed o 5-15 tep\u016f\/min; krevn\u00ed tlak klesne o 10-30 mmHg<\/li>\n<li><strong>Aktivita imidazolin-1 receptor\u016f<\/strong> \u2014 dodate\u010dn\u00fd mechanismus potla\u010duj\u00edc\u00ed sympatikus, specifick\u00fd pro imidazolinov\u00e9 agonisty (klonidin, moxonidin); m\u016f\u017ee p\u0159isp\u00edvat k lep\u0161\u00ed metabolick\u00e9 sn\u00e1\u0161enlivosti ne\u017e u star\u0161\u00edch centr\u00e1ln\u011b p\u016fsob\u00edc\u00edch l\u00e9k\u016f<\/li>\n<li><strong>Spin\u00e1ln\u00ed a supraspin\u00e1ln\u00ed analgetick\u00fd \u00fa\u010dinek<\/strong> \u2014 blokuje p\u0159enos bolestiv\u00fdch sign\u00e1l\u016f v dorz\u00e1ln\u00edm rohu; z\u00e1klad pro intratek\u00e1ln\u00ed pod\u00e1n\u00ed klonidinu p\u0159i chronick\u00e9 bolesti a jako anestetick\u00e9ho adjuvans<\/li>\n<li><strong>Potla\u010den\u00ed noradrenergn\u00edch abstinen\u010dn\u00edch p\u0159\u00edznak\u016f<\/strong> \u2014 sni\u017euje pocen\u00ed, t\u0159es, tachykardii a hypertenzi p\u0159i abstinen\u010dn\u00edch p\u0159\u00edznac\u00edch od opioid\u016f, nikotinu a alkoholu<\/li>\n<li><strong>Zlep\u0161en\u00fd tonus prefront\u00e1ln\u00ed k\u016fry<\/strong> \u2014 navrhovan\u00fd mechanismus pro \u00fa\u010dinek u ADHD (posiluje inhibi\u010dn\u00ed kontrolu shora dol\u016f)<\/li>\n<li><strong>Centr\u00e1ln\u00ed anti-termoregula\u010dn\u00ed \u00fa\u010dinek<\/strong> \u2014 z\u00e1klad pro \u00fa\u010dinek p\u0159i menopauz\u00e1ln\u00edch n\u00e1valy horka<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Schv\u00e1len\u00e9 a v\u011bdecky podlo\u017een\u00e9 indikace<\/h2>\n<ul>\n<li><strong>Rezistentn\u00ed nebo \u010dtvrt\u00e1 linie hypertenze, hypertenzn\u00ed urgentn\u00ed stavy (peror\u00e1ln\u00ed\/sublingu\u00e1ln\u00ed), ADHD, abstinen\u010dn\u00ed p\u0159\u00edznaky od opioid\u016f\/nicotinu, menopauz\u00e1ln\u00ed n\u00e1valy, dopl\u0148kov\u00e1 l\u00e9\u010dba bolesti a anestezie<\/strong><\/li>\n<li><strong>Rezistentn\u00ed hypertenze<\/strong> (\u010dtvrt\u00e1\/p\u00e1t\u00e1 linie)<\/li>\n<li><strong>Hypertenzn\u00ed urgentn\u00ed stav<\/strong> (peror\u00e1ln\u00ed d\u00e1vka 100-200 mcg jako \u00favodn\u00ed d\u00e1vka, pot\u00e9 100 mcg ka\u017edou hodinu) \u2014 ne pro urgentn\u00ed stavy s po\u0161kozen\u00edm c\u00edlov\u00fdch org\u00e1n\u016f<\/li>\n<li><strong>ADHD<\/strong> (schv\u00e1leno FDA jako prodlou\u017een\u00e9 uvol\u0148ov\u00e1n\u00ed Kapvay; standardn\u00ed formy s okam\u017eit\u00fdm uvoln\u011bn\u00edm se pou\u017e\u00edvaj\u00ed off-label glob\u00e1ln\u011b)<\/li>\n<li><strong>Abstinen\u010dn\u00ed p\u0159\u00edznaky od opioid\u016f a nikotinu<\/strong> \u2014 \u00faleva od autonomn\u00edch p\u0159\u00edznak\u016f<\/li>\n<li><strong>Menopauz\u00e1ln\u00ed vazomotorick\u00e9 p\u0159\u00edznaky (n\u00e1valy horka)<\/strong> \u2014 nehormon\u00e1ln\u00ed varianta<\/li>\n<li><strong>Tourett\u016fv syndrom<\/strong> a tikov\u00e9 poruchy<\/li>\n<li><strong>Chronick\u00e1 bolest<\/strong> \u2014 intrathek\u00e1ln\u00ed klonidin pro neuropatickou nebo n\u00e1dorovou bolest<\/li>\n<li><strong>Anestetick\u00e1 premedikace a periopera\u010dn\u00ed t\u0159es<\/strong><\/li>\n<\/ul>\n<p><strong>Kl\u00ed\u010dov\u00e9 d\u016fkazy z klinick\u00fdch studi\u00ed:<\/strong> <strong>VA Cooperative Study on Hypertension (1967-1970)<\/strong> \u2014 klonidin byl prok\u00e1z\u00e1n jako \u00fa\u010dinn\u00e1 monoterapie v \u00e9\u0159e p\u0159ed t\u0159\u00eddami ACE inhibitor\u016f, ARB a CCB. <strong>Subskupinov\u00e9 anal\u00fdzy studie ALLHAT<\/strong> \u2014 re\u017eimy zalo\u017een\u00e9 na klonidinu obecn\u011b sni\u017eovaly TK stejn\u011b \u00fa\u010dinn\u011b jako l\u00e9ky prvn\u00ed volby, ale s hor\u0161\u00ed sn\u00e1\u0161enlivost\u00ed. <strong>Pediatrick\u00e9 studie ADHD Connora a kol.<\/strong> \u2014 klonidin IR \u00fa\u010dinn\u00fd u hyperarousalu a poruch sp\u00e1nku u ADHD, a\u010dkoli psychostimulancia z\u016fst\u00e1vaj\u00ed prvn\u00ed volbou. <strong>Gold et al. (1978)<\/strong> \u2014 pr\u016flomov\u00e1 demonstrace \u00fa\u010dinku klonidinu p\u0159i opi\u00e1tov\u00e9 abstinenci \u2014 odstranil autonomn\u00ed p\u0159\u00edznaky (pocen\u00ed, piloerekce, tachykardie) bez k\u0159\u00ed\u017eov\u00e9 z\u00e1vislosti.<\/p>\n<h2 class=\"wp-block-heading\">D\u00e1vkov\u00e1n\u00ed p\u0159\u00edpravku Arkamin<\/h2>\n<p><strong>Z\u00e1kladn\u00ed d\u00e1vka:<\/strong> <strong>Chronick\u00e1 hypertenze:<\/strong> 100 mcg (0,1 mg) dvakr\u00e1t a\u017e t\u0159ikr\u00e1t denn\u011b, s titrac\u00ed na obvykl\u00e9 maximum 800 mcg\/den. <strong>Nen\u00ed antihypertenzivem prvn\u00ed volby<\/strong> \u2014 vyhrazeno pro \u010dtvrtou\/p\u00e1tou linii po ACEi\/ARB, CCB, thiazidech a spironolaktonu. <strong>Hypertenzn\u00ed urgentn\u00ed stav (peror\u00e1ln\u00ed):<\/strong> 100-200 mcg n\u00e1stupn\u00ed d\u00e1vka, pot\u00e9 100 mcg ka\u017edou hodinu a\u017e do 600 mcg; sni\u017euje TK o 10-20 % b\u011bhem 1-2 hodin. Nen\u00ed ur\u010deno pro hypertenzn\u00ed emergenci (po\u0161kozen\u00ed c\u00edlov\u00fdch org\u00e1n\u016f) \u2014 pou\u017eijte intraven\u00f3zn\u00ed l\u00e1tky.<\/p>\n<p><strong>Dal\u0161\u00ed indikace:<\/strong> <strong>ADHD (d\u011bti a dosp\u00edvaj\u00edc\u00ed):<\/strong> 50\u2013100 mcg p\u0159ed span\u00edm zpo\u010d\u00e1tku, s postupn\u00fdm navy\u0161ov\u00e1n\u00edm na 100\u2013400 mcg\/den v rozd\u011blen\u00fdch d\u00e1vk\u00e1ch. V USA jsou preferov\u00e1ny p\u0159\u00edpravky s prodlou\u017een\u00fdm uvol\u0148ov\u00e1n\u00edm (Kapvay). <strong>Odvyk\u00e1n\u00ed od opioid\u016f (\u00faleva od autonomn\u00edch p\u0159\u00edznak\u016f):<\/strong> 100\u2013300 mcg t\u0159ikr\u00e1t a\u017e \u010dty\u0159ikr\u00e1t denn\u011b, s postupn\u00fdm sni\u017eov\u00e1n\u00edm d\u00e1vky p\u0159i odezn\u00edv\u00e1n\u00ed abstinen\u010dn\u00edch p\u0159\u00edznak\u016f. <strong>N\u00e1valy horka v menopauze:<\/strong> 50\u201375 mcg dvakr\u00e1t denn\u011b. <strong>Tourett\u016fv syndrom:<\/strong> 25\u2013100 mcg dvakr\u00e1t a\u017e t\u0159ikr\u00e1t denn\u011b. <strong>Odvyk\u00e1n\u00ed kou\u0159en\u00ed:<\/strong> 100\u2013300 mcg\/denn\u011b (peror\u00e1ln\u011b nebo transderm\u00e1ln\u011b). <strong>P\u0159edopera\u010dn\u00ed medikace:<\/strong> 200\u2013400 mcg peror\u00e1ln\u011b 60 minut p\u0159ed v\u00fdkonem.<\/p>\n<p><strong>Pod\u00e1v\u00e1n\u00ed:<\/strong> u\u017e\u00edvejte s j\u00eddlem nebo nala\u010dno; ve\u010dern\u00ed d\u00e1vky jsou vy\u0161\u0161\u00ed ne\u017e denn\u00ed, aby se sedativn\u00ed \u00fa\u010dinek p\u0159esunul do sp\u00e1nku. Nevynech\u00e1vejte d\u00e1vky (riziko rebound efektu).<\/p>\n<p><strong>Monitorovac\u00ed pl\u00e1n:<\/strong><\/p>\n<ul>\n<li><strong>Vstupn\u00ed vy\u0161et\u0159en\u00ed:<\/strong> TK vle\u017ee a vestoje (zdokumentujte ortostatick\u00fd pokles), tepov\u00e1 frekvence, EKG (screening bradykardie), seznam l\u00e9k\u016f (kontrola interakc\u00ed).<\/li>\n<li><strong>T\u00fdden 1\u20132:<\/strong> opakovan\u00e9 m\u011b\u0159en\u00ed TK (vle\u017ee a vestoje), tepov\u00e1 frekvence, hodnocen\u00ed p\u0159\u00edznak\u016f. \u00daprava d\u00e1vky podle TK a tolerance.<\/li>\n<li><strong>T\u00fdden 4\u20136:<\/strong> zhodnocen\u00ed c\u00edlov\u00e9ho TK; symptomov\u00e1 z\u00e1t\u011b\u017e; c\u00edlen\u011b se zeptejte na vynechan\u00e9 d\u00e1vky.<\/li>\n<li><strong>Pr\u016fb\u011b\u017en\u00e9:<\/strong> ro\u010dn\u00ed kontrola krevn\u00edho tlaku a srde\u010dn\u00edho stavu; nikdy nedopus\u0165te vy\u010derp\u00e1n\u00ed z\u00e1sob (riziko rebound hypertenze).<\/li>\n<li><strong>P\u0159eru\u0161it l\u00e9\u010dbu nebo sn\u00ed\u017eit d\u00e1vkov\u00e1n\u00ed p\u0159i:<\/strong> t\u011b\u017ek\u00e9 bradykardii, synkop\u011b, AV bloku druh\u00e9ho nebo t\u0159et\u00edho stupn\u011b, t\u011b\u017ek\u00e9 depresi, obt\u011b\u017euj\u00edc\u00ed sedaci bez zlep\u0161en\u00ed po 4-8 t\u00fddnech.<\/li>\n<\/ul>\n<p><strong>Ukon\u010den\u00ed l\u00e9\u010dby:<\/strong> <strong>KRITICK\u00c9 \u2014 nikdy nep\u0159eru\u0161ujte klonidin n\u00e1hle.<\/strong> Rebound hypertenze s n\u00e1r\u016fstem sympatick\u00e9 aktivity se m\u016f\u017ee objevit b\u011bhem 18-36 hodin p\u0159i d\u00e1vk\u00e1ch &gt;300 mcg\/den. <strong>Postupn\u00e9 sni\u017eov\u00e1n\u00ed d\u00e1vky po dobu 2-4 t\u00fddn\u016f<\/strong>; pokud je sou\u010dasn\u011b p\u0159edeps\u00e1n beta-blok\u00e1tor, nejprve vysa\u010fte beta-blok\u00e1tor a pot\u00e9 klonidin. P\u0159i siln\u00e9 bolesti hlavy, bolesti na hrudi nebo TK &gt;180\/110 po vynech\u00e1n\u00ed nebo ukon\u010den\u00ed d\u00e1vek vyhledejte neodkladnou l\u00e9ka\u0159skou pomoc.<\/p>\n<h2 class=\"wp-block-heading\">Praktick\u00e9 pokyny pro Arkamin<\/h2>\n<ul>\n<li><strong>Rebound hypertenze p\u0159i n\u00e1hl\u00e9m ukon\u010den\u00ed l\u00e9\u010dby \u2014 KRITICK\u00c9, potenci\u00e1ln\u011b \u017eivot ohro\u017euj\u00edc\u00ed.<\/strong> Vynechan\u00e9 d\u00e1vky nebo n\u00e1hl\u00e9 ukon\u010den\u00ed mohou zp\u016fsobit n\u00e1r\u016fst sympatick\u00e9 aktivity b\u011bhem 18-36 hodin: vzestup TK o 30-50 mmHg, tachykardii, pocen\u00ed, t\u0159es a vz\u00e1cn\u011b hl\u00e1\u0161en\u00e9 p\u0159\u00edpady c\u00e9vn\u00ed mozkov\u00e9 p\u0159\u00edhody, infarktu myokardu a hypertenzn\u00ed encefalopatie. <strong>V\u017edy sni\u017eujte d\u00e1vku klonidinu postupn\u011b po dobu 2-4 t\u00fddn\u016f<\/strong> nam\u00edsto n\u00e1hl\u00e9ho ukon\u010den\u00ed. Riziko je nejvy\u0161\u0161\u00ed p\u0159i d\u00e1vk\u00e1ch &gt;300 mcg\/den a v kombinaci s beta-blok\u00e1tory.<\/li>\n<li><strong>Transderm\u00e1ln\u00ed n\u00e1plast<\/strong> (Catapres TTS, n\u00e1plasti 100\/200\/300 mcg denn\u011b aplikovan\u00e9 t\u00fddn\u011b) poskytuje stabiln\u011bj\u0161\u00ed hladiny v plazm\u011b a sni\u017euje riziko rebound efektu \u2014 vhodn\u00e9 pro pacienty s probl\u00e9my v adherenci k l\u00e9\u010db\u011b.<\/li>\n<li><strong>Sedace a sucho v \u00fastech<\/strong> jsou t\u00e9m\u011b\u0159 univerz\u00e1ln\u00ed p\u0159i zah\u00e1jen\u00ed l\u00e9\u010dby; obvykle \u010d\u00e1ste\u010dn\u011b ustoup\u00ed b\u011bhem 2\u20134 t\u00fddn\u016f. Hlavn\u00ed d\u00e1vku u\u017e\u00edvejte p\u0159ed span\u00edm, aby se sedace p\u0159esunula do sp\u00e1nku.<\/li>\n<li><strong>Opatrnost p\u0159i kombinovan\u00e9 terapii s betablok\u00e1tory<\/strong> \u2014 pokud l\u00e9\u010dbu ukon\u010dujete, nejprve vysa\u010fte betablok\u00e1tor a pot\u00e9 n\u011bkolik dn\u00ed pot\u00e9 postupn\u011b sni\u017eujte d\u00e1vku klonidinu; opa\u010dn\u00e9 po\u0159ad\u00ed m\u016f\u017ee zp\u016fsobit obzvl\u00e1\u0161t\u011b z\u00e1va\u017en\u00fd rebound efekt, proto\u017ee betablok\u00e1tor blokuje kompenza\u010dn\u00ed reflexy.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n<p><strong>\u010cast\u00e9 (&gt;1 %):<\/strong><\/p>\n<ul>\n<li><strong>Sedace, somnolence<\/strong> (velmi \u010dast\u00e9, zejm\u00e9na prvn\u00ed 2\u20134 t\u00fddny)<\/li>\n<li><strong>Sucho v \u00fastech<\/strong> (velmi \u010dast\u00e9)<\/li>\n<li><strong>Z\u00e1vrat\u011b, ortostatick\u00e1 hypotenze<\/strong><\/li>\n<li><strong>Z\u00e1cpa<\/strong><\/li>\n<li><strong>Erektiln\u00ed dysfunkce a sn\u00ed\u017een\u00e9 libido<\/strong><\/li>\n<li><strong>Deprese, zm\u011bny n\u00e1lady<\/strong><\/li>\n<li><strong>Bradykardie, srde\u010dn\u00ed blok<\/strong> (zejm\u00e9na p\u0159i kombinovan\u00e9 terapii s beta-blok\u00e1tory nebo digoxinem)<\/li>\n<li><strong>P\u0159\u00edr\u016fstek hmotnosti, zadr\u017eov\u00e1n\u00ed sol\u00ed<\/strong> b\u011bhem n\u011bkolika m\u011bs\u00edc\u016f<\/li>\n<li><strong>Ko\u017en\u00ed reakce p\u0159i pou\u017eit\u00ed transderm\u00e1ln\u00ed n\u00e1plasti<\/strong> (kontaktn\u00ed dermatitida u 10-50 % pacient\u016f)<\/li>\n<li><strong>Poruchy sp\u00e1nku, \u017eiv\u00e9 sny, no\u010dn\u00ed m\u016fry<\/strong><\/li>\n<\/ul>\n<p><strong>Nep\u0159\u00edli\u0161 \u010dast\u00e9, ale klinicky v\u00fdznamn\u00e9:<\/strong><\/p>\n<ul>\n<li><strong>Rebound hypertenzn\u00ed krize<\/strong> p\u0159i n\u00e1hl\u00e9m vysazen\u00ed \u2013 byly hl\u00e1\u0161eny p\u0159\u00edpady c\u00e9vn\u00ed mozkov\u00e9 p\u0159\u00edhody, infarktu myokardu a hypertenzn\u00ed encefalopatie.<\/li>\n<li><strong>T\u011b\u017ek\u00e1 bradykardie a atrioventrikul\u00e1rn\u00ed blok<\/strong>, zejm\u00e9na p\u0159i kombinovan\u00e9 terapii s beta-blok\u00e1tory, digoxinem nebo nedihydropyridinov\u00fdmi blok\u00e1tory kalciov\u00fdch kan\u00e1l\u016f (verapamil, diltiazem).<\/li>\n<li><strong>Hlubok\u00e1 sedace<\/strong> naru\u0161uje pr\u00e1ci nebo \u0159\u00edzen\u00ed \u2014 u n\u011bkter\u00fdch pacient\u016f limituj\u00edc\u00ed d\u00e1vkov\u00e1n\u00ed.<\/li>\n<li><strong>Deprese<\/strong> nebo zhor\u0161en\u00ed ji\u017e existuj\u00edc\u00ed deprese.<\/li>\n<li><strong>Dysfunkce sinusov\u00e9ho uzlu, synkopa<\/strong>.<\/li>\n<li><strong>T\u011b\u017ek\u00e1 alergick\u00e1 kontaktn\u00ed dermatitida p\u0159i pou\u017eit\u00ed transderm\u00e1ln\u00ed n\u00e1plasti<\/strong> \u2014 st\u0159\u00eddejte m\u00edsta aplikace; p\u0159i z\u00e1va\u017en\u00e9 reakci p\u0159eru\u0161te l\u00e9\u010dbu.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kontraindikace<\/h2>\n<ul>\n<li>Zn\u00e1m\u00e1 p\u0159ecitliv\u011blost na klonidin<\/li>\n<li>T\u011b\u017ek\u00e1 bradyarytmie, syndrom nemocn\u00e9ho sinu, AV blok druh\u00e9ho nebo t\u0159et\u00edho stupn\u011b bez kardiostimul\u00e1toru<\/li>\n<li>T\u011b\u017ek\u00e1 deprese (relativn\u00ed kontraindikace)<\/li>\n<li>Sou\u010dasn\u00e9 u\u017e\u00edv\u00e1n\u00ed dal\u0161\u00edch centr\u00e1ln\u00edch agonist\u016f alfa-2 (methyldopa, tizanidin) \u2014 aditivn\u00ed hypotenze a sedace<\/li>\n<li>T\u011bhotenstv\u00ed: obecn\u011b se nedoporu\u010duje (preferuje se methyldopa nebo labetalol); data jsou omezen\u00e1, nen\u00ed jasn\u011b teratogenn\u00ed, ale zku\u0161enosti s alternativami jsou mnohem v\u011bt\u0161\u00ed<\/li>\n<li>Kojen\u00ed: v\u00fdznamn\u011b p\u0159ech\u00e1z\u00ed do mate\u0159sk\u00e9ho ml\u00e9ka<\/li>\n<\/ul>\n<p><strong>T\u011bhotenstv\u00ed:<\/strong> obecn\u011b se nedoporu\u010duje jako prvn\u00ed volba \u2014 methyldopa a labetalol maj\u00ed rozs\u00e1hlej\u0161\u00ed bezpe\u010dnostn\u00ed datab\u00e1ze. Klonidin nen\u00ed jasn\u011b teratogenn\u00ed a n\u011bkdy se pou\u017e\u00edv\u00e1 jako dopl\u0148kov\u00e1 terapie u rezistentn\u00ed gesta\u010dn\u00ed hypertenze.<\/p>\n<p><strong>Kojen\u00ed:<\/strong> v\u00fdznamn\u00fd p\u0159enos do mate\u0159sk\u00e9ho ml\u00e9ka \u2014 sledujte u kojence zn\u00e1mky sedace, bradykardie a \u0161patn\u00e9ho p\u0159\u00edjmu potravy; zva\u017ete alternativn\u00ed l\u00e9\u010dbu.<\/p>\n<h2 class=\"wp-block-heading\">Interakce s l\u00e9\u010divy<\/h2>\n<ul>\n<li><strong>Betablok\u00e1tory \u2014 KRITICK\u00c9.<\/strong> Spole\u010dn\u00e1 l\u00e9\u010dba zhor\u0161uje rebound hypertenzi p\u0159i vysazen\u00ed klonidinu. Pokud jsou oba l\u00e9ky vysazov\u00e1ny sou\u010dasn\u011b, nejprve vysa\u010fte betablok\u00e1tor o n\u011bkolik dn\u00ed d\u0159\u00edve, pot\u00e9 postupn\u011b sni\u017eujte d\u00e1vku klonidinu. Betablok\u00e1tory tak\u00e9 zvy\u0161uj\u00ed riziko bradykardie v kombinaci s klonidinem.<\/li>\n<li><strong>Digoxin, nedihydropyridinov\u00e9 CCB (verapamil, diltiazem)<\/strong> \u2014 aditivn\u00ed bradykardie a AV blok.<\/li>\n<li><strong>Tricyklick\u00e1 antidepresiva a alfa-antagonist\u00e9<\/strong> \u2014 \u010d\u00e1ste\u010dn\u011b antagonizuj\u00ed antihypertenzn\u00ed \u00fa\u010dinek klonidinu; m\u016f\u017ee b\u00fdt nutn\u00e9 zv\u00fd\u0161it d\u00e1vku klonidinu.<\/li>\n<li><strong>CNS depresiva (opioidy, benzodiazepiny, alkohol, gabapentinoidy)<\/strong> \u2014 aditivn\u00ed sedace.<\/li>\n<li><strong>Jin\u00e1 centr\u00e1ln\u011b p\u016fsob\u00edc\u00ed antihypertenziva (methyldopa, tizanidin, moxonidin)<\/strong> \u2014 aditivn\u00ed sedace a hypotenze; obvykle se nekombinuje.<\/li>\n<li><strong>Mirtazapin<\/strong> \u2014 antagonismus alfa-2 sni\u017euje \u00fa\u010dinek klonidinu.<\/li>\n<li><strong>Diuretika<\/strong> \u2014 synergn\u00ed sn\u00ed\u017een\u00ed TK; standardn\u00ed kombinace u rezistentn\u00ed hypertenze.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">M\u00edsto p\u0159\u00edpravku Arkamin v hierarchii antihypertenziv<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">\u00darove\u0148<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">T\u0159\u00edda \/ P\u0159\u00edklady<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Role<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Prvn\u00ed volba<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">ACE inhibitory (<a href=\"https:\/\/medsbase.com\/cs\/ramcor\/\">ramipril<\/a>), sartany (<a href=\"https:\/\/medsbase.com\/cs\/telmaheal\/\">telmisartan<\/a>), blok\u00e1tory kalciov\u00fdch kan\u00e1l\u016f (<a href=\"https:\/\/medsbase.com\/cs\/amlode\/\">amlodipin<\/a>), thiazidy (<a href=\"https:\/\/medsbase.com\/cs\/natrilix-sr\/\">indapamid<\/a>, HCTZ)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Za\u010dn\u011bte zde u nov\u011b diagnostikovan\u00e9 hypertenze<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Druh\u00fd\/t\u0159et\u00ed l\u00e9k<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Kombinace v\u00fd\u0161e uveden\u00e9ho (ACEi+CCB, ARB+thiazid)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Pokud jeden l\u00e9k nesta\u010d\u00ed<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">\u010ctvrt\u00fd l\u00e9k (rezistentn\u00ed hypertenze)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/cs\/aldactone\/\">Spironolakton<\/a> (d\u016fkaz z PATHWAY-2); beta-blok\u00e1tor; doxazosin<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Pokud TK nen\u00ed kontrolov\u00e1n na t\u0159\u00edl\u00e9kov\u00e9 kombinaci v pln\u00e9 d\u00e1vce<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">P\u00e1t\u00fd l\u00e9k<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Alfa-blok\u00e1tory<\/strong> (<a href=\"https:\/\/medsbase.com\/cs\/prazopress\/\">prazosin<\/a>, <a href=\"https:\/\/medsbase.com\/cs\/hytrin\/\">terazosin<\/a>, doxazosin); centr\u00e1ln\u011b p\u016fsob\u00edc\u00ed l\u00e1tky<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">P\u0159idat, pokud je spironolakton nedostate\u010dn\u00fd nebo kontraindikovan\u00fd; preferujte alfa-blok\u00e1tory p\u0159i sou\u010dasn\u00e9m BPH<\/td>\n<\/tr>\n<tr style=\"background:#fff3cd;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">P\u00e1t\u00fd \/ \u0161est\u00fd l\u00e9k<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Centr\u00e1ln\u011b p\u016fsob\u00edc\u00ed l\u00e1tky<\/strong> (<a href=\"https:\/\/medsbase.com\/cs\/arkamin\/\">klonidin<\/a>, moxonidin<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">P\u0159idat k dosa\u017een\u00ed c\u00edlov\u00fdch hodnot u rezistentn\u00ed hypertenze; sledovat riziko rebound efektu a sedace<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">L\u00e9k prvn\u00ed volby v t\u011bhotenstv\u00ed<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong><a href=\"https:\/\/medsbase.com\/cs\/alphadopa\/\">Methyldopa<\/a><\/strong>, <a href=\"https:\/\/medsbase.com\/cs\/labebet\/\">labetalol<\/a>, nifedipin<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Gestan\u010dn\u00ed hypertenze a preexistuj\u00edc\u00ed hypertenze v t\u011bhotenstv\u00ed<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Skladov\u00e1n\u00ed<\/h2>\n<p>Skladujte Arkamin p\u0159i teplot\u011b pod 25\u00b0C v p\u016fvodn\u00edm blistru. Uchov\u00e1vejte mimo dosah d\u011bt\u00ed.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">Pro\u010d je tak nebezpe\u010dn\u00e9 vynechat d\u00e1vky Arkaminu?<\/h3>\n<p>Klonidin potla\u010duje centr\u00e1ln\u00ed sympatick\u00fd v\u00fddej. Kdy\u017e hladiny klonidinu n\u00e1hle poklesnou, ulo\u017een\u00fd sympatick\u00fd n\u00e1boj \u201codsko\u010d\u00ed\u201d b\u011bhem 18-36 hodin \u2014 krevn\u00ed tlak prudce stoupne o 30-50 mmHg, zvy\u0161uje se srde\u010dn\u00ed frekvence a pacient se pot\u00ed, t\u0159ese a m\u00e1 siln\u00e9 bolesti hlavy. P\u0159\u00edpadov\u00e9 zpr\u00e1vy popisuj\u00ed rebound mrtvici, infarkt myokardu a hypertenzn\u00ed encefalopatii. Toto riziko je nejv\u011bt\u0161\u00ed p\u0159i d\u00e1vk\u00e1ch nad 300 mcg\/den a p\u0159i sou\u010dasn\u00e9 beta-blok\u00e1d\u011b. <strong>Nikdy nep\u0159est\u00e1vejte s klonidinem n\u00e1hle<\/strong> \u2014 sni\u017eujte d\u00e1vku postupn\u011b po dobu 2-4 t\u00fddn\u016f pod l\u00e9ka\u0159sk\u00fdm dohledem. V\u017edy si objednejte novou dod\u00e1vku 1-2 t\u00fddny p\u0159ed vy\u010derp\u00e1n\u00edm z\u00e1sob.<\/p>\n<h3 class=\"wp-block-heading\">Zp\u016fsob\u00ed Arkamin ospalost?<\/h3>\n<p>Ano \u2014 sedace a denn\u00ed ospalost jsou nej\u010dast\u011bj\u0161\u00edmi st\u00ed\u017enostmi, kter\u00e9 postihuj\u00ed a\u017e polovinu pacient\u016f v prvn\u00edch 2-4 t\u00fddnech. Obvykle se v\u00fdrazn\u011b zlep\u0161\u00ed do 4-6 t\u00fddne. Strategie: p\u0159esu\u0148te v\u011bt\u0161\u00ed \u010d\u00e1st denn\u00ed d\u00e1vky na dobu p\u0159ed span\u00edm, aby k sedaci doch\u00e1zelo b\u011bhem sp\u00e1nku; vyhn\u011bte se alkoholu a dal\u0161\u00edm CNS depresiv\u016fm; ne\u0159i\u010fte ani neobsluhujte stroje, dokud nev\u00edte, jak na v\u00e1s Arkamin p\u016fsob\u00ed. Pokud sedace z\u016fst\u00e1v\u00e1 nep\u0159ijateln\u00e1 po 6-8 t\u00fddnech, p\u0159ejd\u011bte na alternativu (moxonidin, methyldopa pouze v t\u011bhotenstv\u00ed nebo jinou t\u0159\u00eddu antihypertenziv).<\/p>\n<h3 class=\"wp-block-heading\">Mohu u\u017e\u00edvat Arkamin s alkoholem?<\/h3>\n<p>Ob\u010dasn\u00e1 konzumace mal\u00e9ho mno\u017estv\u00ed alkoholu je obvykle tolerov\u00e1na. Pravideln\u00e1 nebo nadm\u011brn\u00e1 konzumace alkoholu v\u00fdrazn\u011b zesiluje ortostatickou hypotenzi a sedaci Arkaminu \u2014 zvy\u0161uje se pravd\u011bpodobnost p\u00e1d\u016f, bezv\u011bdom\u00ed a nehod. Pacienti s vy\u0161\u0161\u00edm rizikem (star\u0161\u00ed lid\u00e9, p\u0159edchoz\u00ed p\u00e1dy, sou\u010dasn\u00e9 u\u017e\u00edv\u00e1n\u00ed diuretik nebo sedativ) by se m\u011bli alkoholu p\u0159i u\u017e\u00edv\u00e1n\u00ed tohoto l\u00e9ku zcela vyhnout.<\/p>\n<h3 class=\"wp-block-heading\">M\u016f\u017ee se Arkamin pou\u017e\u00edvat na ADHD?<\/h3>\n<p>Ano \u2014 klonidin je ve Spojen\u00fdch st\u00e1tech schv\u00e1len FDA jako prodlou\u017een\u00e9 uvol\u0148ov\u00e1n\u00ed <strong>Kapvay<\/strong> pro ADHD u d\u011bt\u00ed a dosp\u00edvaj\u00edc\u00edch a je pou\u017e\u00edv\u00e1n off-label (jako okam\u017eit\u00e9 uvoln\u011bn\u00ed) mezin\u00e1rodn\u011b. Nen\u00ed l\u00e9kem prvn\u00ed volby (psychostimulancia \u2014 methylfenid\u00e1t, amfetaminy \u2014 maj\u00ed v\u011bt\u0161\u00ed st\u0159edn\u00ed \u00fa\u010dinky na z\u00e1kladn\u00ed p\u0159\u00edznaky ADHD), ale klonidin m\u00e1 specifick\u00e9 m\u00edsto p\u0159i hyperarousalu, us\u00edn\u00e1n\u00ed, tic\u00edch a zvl\u00e1d\u00e1n\u00ed vedlej\u0161\u00edch \u00fa\u010dink\u016f stimulanci\u00ed. Typick\u00e1 d\u011btsk\u00e1 d\u00e1vka: 50-100 mcg p\u0159ed span\u00edm zpo\u010d\u00e1tku, s titrac\u00ed na 100-400 mcg\/den v rozd\u011blen\u00fdch d\u00e1vk\u00e1ch pod odborn\u00fdm dohledem.<\/p>\n<h3 class=\"wp-block-heading\">Co kdy\u017e vynech\u00e1m d\u00e1vku?<\/h3>\n<p><strong>Vynechanou d\u00e1vku u\u017eijte co nejd\u0159\u00edve, jak si vzpomenete<\/strong>, i kdy\u017e je bl\u00edzko dal\u0161\u00ed pl\u00e1novan\u00e9 d\u00e1vky \u2014 riziko rebound hypertenze u klonidinu znamen\u00e1, \u017ee vynechan\u00e9 d\u00e1vky mus\u00ed b\u00fdt rychle nahrazeny. Pokud si vzpomenete do 6 hodin, u\u017eijte vynechanou d\u00e1vku a pokra\u010dujte jako obvykle. Pokud uplynulo v\u00edce ne\u017e 12 hodin a objevuj\u00ed se rebound p\u0159\u00edznaky (siln\u00e1 bolest hlavy, palpitace, pocen\u00ed), u\u017eijte d\u00e1vku a vyhledejte neodkladnou l\u00e9ka\u0159skou kontrolu. Nikdy si nenechte doj\u00edt z\u00e1soby \u2014 objedn\u00e1vejte opakovan\u00e9 recepty 1-2 t\u00fddny p\u0159ed vy\u010derp\u00e1n\u00edm sou\u010dasn\u00fdch z\u00e1sob.<\/p>\n<h3 class=\"wp-block-heading\">Mohu p\u0159estat u\u017e\u00edvat Arkamin, pokud m\u00e1m krevn\u00ed tlak pod kontrolou?<\/h3>\n<p><strong>Ne n\u00e1hle.<\/strong> Rebound hypertenze do 18-36 hodin po vysazen\u00ed klonidinu m\u016f\u017ee vyvolat c\u00e9vn\u00ed mozkovou p\u0159\u00edhodu, infarkt myokardu nebo hypertenzn\u00ed encefalopatii. V\u017edy sni\u017eujte d\u00e1vkov\u00e1n\u00ed postupn\u011b po dobu 2-4 t\u00fddn\u016f pod l\u00e9ka\u0159sk\u00fdm dohledem. Pokud u\u017e\u00edv\u00e1te betablok\u00e1tor, nejprve vysa\u010fte betablok\u00e1tor a a\u017e o n\u011bkolik dn\u00ed pozd\u011bji za\u010dn\u011bte s postupn\u00fdm vysazov\u00e1n\u00edm klonidinu.<\/p>\n<h3 class=\"wp-block-heading\">Mohu u\u017e\u00edvat Arkamin v t\u011bhotenstv\u00ed?<\/h3>\n<p>Obecn\u011b ne. L\u00e9ky volby pro hypertenzi v t\u011bhotenstv\u00ed jsou methyldopa, labetalol a nifedipin \u2014 Arkamin nen\u00ed v t\u011bhotenstv\u00ed l\u00e9kem prvn\u00ed volby. P\u0159ed po\u010det\u00edm nebo ihned po potvrzen\u00ed t\u011bhotenstv\u00ed p\u0159ejd\u011bte pod odborn\u00fdm dohledem na jeden z t\u011bchto l\u00e9k\u016f.<\/p>\n<h3 class=\"wp-block-heading\">Kde lze koupit Arkamin online?<\/h3>\n<p>Arkamin (100 mcg klonidinu, 30-90 tablet) m\u016f\u017eete zakoupit na MedsBase s diskr\u00e9tn\u00edm balen\u00edm a celosv\u011btovou dopravou.<\/p>\n<h2 class=\"wp-block-heading\">Souvisej\u00edc\u00ed antihypertenziva na MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/aldactone\/\">Aldactone \u2014 Spironolakton 25\/50\/100 mg (PATHWAY-2 4. linie)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/alphadopa\/\">Alphadopa \u2014 Methyldopa 250 mg (bezpe\u010dn\u00e1 pro t\u011bhotn\u00e9 s hypertenz\u00ed)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/hytrin\/\">Hytrin \u2014 Terazosin 1\/2\/5 mg (AbbVie)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/minipress-xl\/\">Minipress XL \u2014 Prazosin ER 2,5\/5 mg (Pfizer)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/ramcor\/\">Ramcor \u2014 Ramipril 2,5\/5\/10 mg (ACE inhibitor)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/telma-h\/\">Telma H \u2014 Telmisartan + HCTZ kombinace<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/high-blood-pressure-medication\/\"><strong>Prohl\u00e9dnout v\u0161echny l\u00e9ky na vysok\u00fd krevn\u00ed tlak<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 L\u00e9ka\u0159sk\u00e9 upozorn\u011bn\u00ed.<\/strong> Tato str\u00e1nka slou\u017e\u00ed pouze pro informa\u010dn\u00ed \u00fa\u010dely a nenahrazuje l\u00e9ka\u0159skou p\u00e9\u010di kvalifikovan\u00e9ho zdravotnick\u00e9ho pracovn\u00edka. Hypertenze, srde\u010dn\u00ed selh\u00e1n\u00ed a arytmie vy\u017eaduj\u00ed diagn\u00f3zu, monitorov\u00e1n\u00ed a individu\u00e1ln\u00ed d\u00e1vkov\u00e1n\u00ed l\u00e9ka\u0159em \u2014 v\u017edy u\u017e\u00edvejte betablok\u00e1tory pod l\u00e9ka\u0159sk\u00fdm dohledem.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy<\/h3>\n<p>Dal\u0161\u00ed produkty v <strong>Chronick\u00e1 onemocn\u011bn\u00ed<\/strong> kter\u00e9 z\u00e1kazn\u00edci tak\u00e9 prohl\u00ed\u017eej\u00ed:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/robinax\/\">Robinax<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/affexor-xr\/\">Affexor XR<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/xyzal\/\">Xyzal<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/duolin-inhaler\/\">Duolin Inhaler<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/noltrexate\/\">Noltrexate<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Arkamin jsou tablety klonidinu 100 mcg od spole\u010dnosti Torrent Pharma \u2014 p\u016fvodn\u00ed centr\u00e1ln\u011b p\u016fsob\u00edc\u00ed agonista alfa-2 adrenergn\u00edch receptor\u016f (Catapres od Boehringer Ingelheim, 1966). Sni\u017euje centr\u00e1ln\u00ed sympatick\u00fd v\u00fddej; sni\u017euje perifern\u00ed noradrenalin o 30-50%. Pou\u017eit\u00ed: hypertenze \u010dtvrt\u00e9\/p\u00e1t\u00e9 linie, hypertenzn\u00ed urgentn\u00ed stavy, ADHD (v USA schv\u00e1leno jako Kapvay XR), abstinen\u010dn\u00ed p\u0159\u00edznaky u opioid\u016f a nikotinu, n\u00e1valy horka v menopauze, Tourett\u016fv syndrom, anestetick\u00e1 podpora. KRITICK\u00c9 \u2014 nikdy nep\u0159est\u00e1vejte n\u00e1hle (riziko rebound hypertenze s mo\u017enost\u00ed c\u00e9vn\u00ed mozkov\u00e9 p\u0159\u00edhody nebo infarktu myokardu).<\/p>","protected":false},"featured_media":51443,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[3357,3358],"class_list":{"0":"post-51442","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_cat-high-blood-pressure-medication","10":"product_tag-arkamin","11":"product_tag-clonidine","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/51442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=51442"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/51443"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=51442"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=51442"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=51442"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=51442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}